CAV1 immunostaining was performed in order to investigate CAV1 expression levels as well as epithelial-stromal CAV1 distributions in penile carcinoma specimen according to the p16 (as a surrogate marker for the HPV infection) and p53 (TP53) status (Figure 1). The gene discussed is CAV1; the disease is penile carcinoma.